| Schedule of Earnings Per Share |
The following table summarizes the weighted-average number of basic common shares outstanding and the calculation of basic earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
|
For the Six Months Ended March 31, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Numerator |
|
|
|
|
|
|
|
| Net income (loss) attributable to common stockholders |
$ |
4,215 |
|
|
$ |
(1,124) |
|
|
$ |
1,164 |
|
|
$ |
8,719 |
|
| Denominator |
|
|
|
|
|
|
|
| Weighted average number of common shares outstanding, basic |
55,248,526 |
|
|
51,938,216 |
|
|
54,698,442 |
|
|
51,915,069 |
|
| Net income (loss) per common share attributable to common stockholders, basic |
$ |
0.08 |
|
|
$ |
(0.02) |
|
|
$ |
0.02 |
|
|
$ |
0.17 |
|
|
|
|
|
|
|
|
|
The following table summarizes the calculation of the weighted-average number of diluted common shares outstanding and the calculation of diluted earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
|
For the Six Months Ended March 31, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Numerator |
|
|
|
|
|
|
|
| Net income (loss) attributable to common stockholders |
$ |
4,215 |
|
|
$ |
(1,124) |
|
|
$ |
1,164 |
|
|
$ |
8,719 |
|
| Denominator |
|
|
|
|
|
|
|
| Weighted average number of basic common shares outstanding, basic |
55,248,526 |
|
|
51,938,216 |
|
|
54,698,442 |
|
|
51,915,069 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock grants |
421,120 |
|
|
— |
|
|
442,916 |
|
|
608,031 |
|
| Weighted average number of diluted common shares outstanding: |
55,669,646 |
|
|
51,938,216 |
|
|
55,141,358 |
|
|
52,523,100 |
|
| Net income (loss) per diluted common share attributable to common stockholders |
$ |
0.08 |
|
|
$ |
(0.02) |
|
|
$ |
0.02 |
|
|
$ |
0.17 |
|
|
|
|
|
|
|
|
|
|